Literature DB >> 3033237

Tetracyclines inhibit human synovial collagenase in vivo and in vitro.

R A Greenwald, L M Golub, B Lavietes, N S Ramamurthy, B Gruber, R S Laskin, T F McNamara.   

Abstract

To determine if tetracyclines can inhibit human synovial collagenase from rheumatoid tissue, paired synovial tissue (or synovial fluid) was collected from 7 patients before and after oral administration of minocycline (100 mg BID) for 10 days. With each patient serving as his own control, the postminocycline collagenase activities fell an average of 67% from pretreatment values. Qualitative SDS-PAGE revealed decreased loss of alpha collagen components and reduced formation of alpha A digestion fragments. Addition of minocycline or a chemically modified tetracycline to synovial culture media in vitro profoundly inhibited collagenase activity. Further study of this action of tetracyclines could serve as a probe of the role of collagenase in rheumatoid arthritis and lead to development of agents capable of modifying the tissue destructive actions of collagenase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033237

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  29 in total

Review 1.  Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis?

Authors:  J R O'Dell
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

Review 2.  Combination therapy for autoimmune diseases: the rheumatoid arthritis model.

Authors:  N Fathy; D E Furst
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Benefits and risks of minocycline in rheumatoid arthritis.

Authors:  P Langevitz; A Livneh; I Bank; M Pras
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

4.  Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine.

Authors:  R Gendron; D Grenier; T Sorsa; D Mayrand
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 5.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

6.  Effects of minocycline-HCl paste root conditioning on periodontal surgery: in vitro and in vivo studies.

Authors:  Huihui Zhang; Xi Yang; Chengzhang Li; Shuhuan Shang; Jiaxi Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

7.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.

Authors:  L Shapira; W A Soskolne; Y Houri; V Barak; A Halabi; A Stabholz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes.

Authors:  M Kloppenburg; B M Brinkman; H H de Rooij-Dijk; A M Miltenburg; M R Daha; F C Breedveld; B A Dijkmans; C Verweij
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 9.  Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Authors:  Pamela Mangat; Natalia Wegner; Patrick J Venables; Jan Potempa
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

Review 10.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.